Abbott Laboratories - 33 Year Dividend History | ABT

Historical dividend payout and yield for Abbott Laboratories (ABT) since 1985. The current TTM dividend payout for Abbott Laboratories (ABT) as of August 14, 2018 is $1.12. The current dividend yield for Abbott Laboratories as of August 14, 2018 is 1.77%.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $111.276B $27.390B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $122.654B 18.98
Stryker (SYK) United States $62.124B 24.00
Boston Scientific (BSX) United States $46.051B 23.96
Baxter (BAX) United States $37.778B 25.71
Zimmer Biomet Holdings (ZBH) United States $24.917B 16.01
Smith & Nephew SNATS (SNN) United Kingdom $15.439B 0.00
ResMed (RMD) United States $15.234B 30.24
Bio-Rad Laboratories (BIO) United States $9.625B 61.86
Perrigo (PRGO) Ireland $9.529B 13.52
Hill-Rom Holdings (HRC) United States $6.247B 21.19
ICU Medical (ICUI) United States $6.000B 40.66
Canopy Growth (CGC) Canada $5.894B 0.00
Haemonetics (HAE) United States $5.175B 47.22
Insulet (PODD) United States $5.112B 0.00
Agios Pharmaceuticals (AGIO) United States $4.487B 0.00
Neogen (NEOG) United States $4.317B 68.78
Hutchison China MediTech (HCM) China $4.179B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.671B 0.00
NuVasive (NUVA) United States $3.382B 32.08
National Vision Holdings (EYE) United States $3.296B 0.00
Quidel (QDEL) United States $2.733B 56.00
Phibro Animal Health (PAHC) United States $2.018B 29.97
NxStage Medical (NXTM) United States $1.853B 0.00
Cardiovascular Systems (CSII) United States $1.239B 744.80
Eagle Pharmaceuticals (EGRX) United States $1.188B 35.07
AtriCure (ATRC) United States $1.089B 0.00
VAREX IMAGING (VREX) United States $1.086B 17.75
OraSure Technologies (OSUR) United States $1.015B 66.36
Orthofix (OFIX) United States $1.002B 30.51
TG Therapeutics (TGTX) United States $0.969B 0.00
Cerus (CERS) United States $0.958B 0.00
Surmodics (SRDX) United States $0.947B 114.43
Omeros (OMER) United States $0.931B 0.00
Owens & Minor (OMI) United States $0.930B 9.95
MacroGenics (MGNX) United States $0.870B 0.00
LeMaitre Vascular (LMAT) United States $0.705B 33.81
PetIQ (PETQ) United States $0.668B 0.00
Meridian Bioscience (VIVO) United States $0.632B 21.59
Insys Therapeutics (INSY) United States $0.555B 0.00
Evolus (EOLS) United States $0.534B 0.00
Lantheus Holdings (LNTH) United States $0.511B 15.89
NanoString Technologies (NSTG) United States $0.415B 0.00
Cytosorbents (CTSO) United States $0.359B 0.00
Utah Medical Products (UTMD) United States $0.341B 21.97
BioLife Solutions (BLFS) United States $0.338B 0.00
Quanterix (QTRX) United States $0.326B 0.00
Surface Oncology (SURF) United States $0.269B 0.00
Rockwell Medical (RMTI) United States $0.247B 0.00
Chimerix (CMRX) United States $0.206B 0.00
Fonar (FONR) United States $0.168B 10.19
Chembio Diagnostics (CEMI) United States $0.163B 0.00
Bovie Medical (BVX) United States $0.158B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.119B 0.00
Female Health (VERU) United States $0.110B 0.00
Trinity Biotech (TRIB) Ireland $0.090B 26.75
United-Guardian (UG) United States $0.086B 18.84
Oramed Pharmaceuticals (ORMP) Israel $0.085B 0.00
Neurotrope (NTRP) United States $0.077B 0.00
InfuSystems Holdings (INFU) United States $0.072B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.065B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Capricor Therapeutics (CAPR) United States $0.031B 0.00
Akers Biosciences Inc (AKER) United States $0.025B 0.00
Myomo (MYO) United States $0.025B 0.00
Senestech (SNES) United States $0.018B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.008B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00